poisar

Stocks · News reference

IM Cannabis Leverages Restructuring Deal to Reduce Financial Strain

BenzingaVandana Singh

IM Cannabis enters a definitive deal to sell its subsidiary to Slil, aiming to boost equity and focus on Israeli assets.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaBenzinga Newsdesk

    IM Cannabis Shares Start Trading On 30-For-1 Split Basis

    IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press release dated August 18, 2026, the